Skip to content

How does cartalax work?

Cartalax is Ala-Glu-Asp, a three-amino-acid peptide also written AED or Kartalax. This site's profile suggests it works by changing which genes are switched on: a very short peptide that gets into the cell and interacts with DNA and the proteins it wraps around. Its half-life is not known. No study of how the body handles it, in people or animals, was found. Its molecular weight is about 333 daltons. This site's review found no primary human study. The only claim about people is one sentence in a 2023 review from the institute that created it. The published work on how it works is all in cells in a lab. AED and a cartilage peptide mix brought aging markers in cartilage cells back toward normal. Short peptides changed which genes were active in aged human stem cells in a dish. Cartilage cells in a dish are not a joint, and those findings do not transfer into a counted human cartilage mechanism. This FAQ does not invent a human mechanism. Full record at /compounds/cartalax.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of immune and longevity peptides. Thymosin alpha-1, thymalin, epitalon, MOTS-c, humanin, and the bioregulator family.

Others in immune and longevity peptides

All 723 questions